Background illustration for clinical trials search

Skin Cancer Clinical Trials

Browse 473 skin cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

IL-17 Blockade to Decrease irAEs (REPLAY)

for
Metastatic Melanoma
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07237594

Phase1, Recruiting

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

for
Advanced NRAS-Mutant Melanoma,
Location: Boston MA, New York NY, Fairfax VA, Grand Rapids MI,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07584226

Phase1, Recruiting

A Study of BI 3810944 in Patients With Advanced Cancer

for
Solid Tumours, Melanoma
Location: Louisville KY, Nashville TN
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07224425

Phase1, Recruiting

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

for
Uveal Melanoma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07364474

Recruiting

Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma

for
Melanoma Metastatic
Location: Toronto
Sponsor: Melanoma Institute Australia

Sex: All

Age: 18+

Code: NCT06767306

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

for
Refractory Melanoma
Location: Boston MA, Morristown NJ, Chapel Hill NC, Birmingham AL,
Sponsor: Diakonos Oncology Corporation

Sex: All

Age: 18+

Code: NCT07288112

Phase1, Phase2, Recruiting

Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients

for
Melanoma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07379138

Recruiting

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

for
Melanoma, Metastatic Melanoma, Advanced Solid Tumor,
Location: La Jolla CA
Sponsor: Replimune Inc.

Sex: All

Age: 18+

Code: NCT06887348

Recruiting

Tebentafusp-tebn With LDT in Metastatic UM

for
Metastatic Uveal Melanoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT06626516

Phase1, Phase2, Recruiting

Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

for
Locally Advanced Melanoma
Location: Pittsburgh PA
Sponsor: John Kirkwood

Sex: All

Age: 18+

Code: NCT07223411

Recruiting

Adjuvant Tebentafusp in High Risk Ocular Melanoma

for
Uveal Melanoma
Location: Lake Success NY
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT06246149

Phase3, Recruiting

Neoadjuvant Darovasertib in Primary Uveal Melanoma

for
Uveal Melanoma
Location: New York NY, Baltimore MD, Toronto, Jacksonville FL,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07015190

Phase3, Recruiting

Neoadjuvant Tebentafusp for Uveal Melanoma

for
Locally Advanced Unresectable Uveal Melanoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT06414590

Phase2, Recruiting

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

for
Melanoma, Brain Metastases
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06712927

Phase2, Recruiting

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

for
Metastatic Melanoma, Advanced Melanoma
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT07504796

Phase2, Recruiting

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

for
Metastatic Melanoma, OligoProgressive Metastatic Disease
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07112170

Recruiting

AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

for
Advanced Melanoma and Normal or Impaired, Advanced Melanoma
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07027488

Phase1, Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

for
Malignant Melanoma
Location: Hackensack NJ, Fairfax VA, Toronto, Brampton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06961006

Phase2, Recruiting

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

for
Melanoma, Medullary Thyroid Cancer,
Location: Tucson AZ, Seattle WA
Sponsor: University of Arizona

Sex: All

Age: 18 - 70+

Code: NCT06814496

Phase1, Phase2, Recruiting

In Vivo Real-time Detection of Circulating Melanoma Cells

for
Melanoma
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: All

Age: 18 - 70+

Code: NCT01776905

Recruiting